Pars Plana Vitrectomy versus Intravitreal Injection of Ranibizumab in the Treatment of Diabetic Macular Edema Associated with Vitreomacular Interface Abnormalities

Figure 3

Sample cases from group I. Case 1: (a) baseline OCT scan of DME with concurrent ERM, CDVA 0.3; and (b) OCT scan at the end of the study after 4 IVIs of RBZ with resolution of the central DME, CDVA improved to 0.18. Case 2: (c) baseline OCT scan of DME with concurrent ERM, CDVA 0.6; and (d) OCT scan after 6 IVIs of RBZ with persistent nonresponding DME, CDVA 0.7. Case 3: (e) baseline OCT scan of DME with concurrent focal VMT, CDVA 0.6; and (f) OCT scan after 6 IVIs of RBZ partial improvement in parafoveal edema, progression of VMT, and persistent central DME, CDVA 0.6.

(a)

(b)

(c)

(d)

(e)

(f)